Industry experts talk about some of the new challenges facing clinical trial sites I 2024.
Think real-world data’s only application is clinical trials? Think again. Savvy early-stage biotechs are leveraging RWD in their formative stages, long before entering the clinic, to drive critical efficiencies in drug discovery and development.
To start singling-out where the opportunities exist to craft the next generation of RNA therapeutics, Ann Rose Welch sat down with four RNA executives.
A baker’s dozen of biopharma CEOs answer a call to prioritize and describe challenges they expect to face in the coming year.
Get the latest articles from Life Science Leader delivered to your inbox.